Artemis Investment Management’s Bio-Rad Laboratories Class A BIO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-194,607
| Closed | -$81.3M | – | 224 |
|
|
2022
Q3 | $81.3M | Sell |
194,607
-1,180
| -0.6% | -$493K | 0.93% | 36 |
|
|
2022
Q2 | $97M | Buy |
195,787
+96,691
| +98% | +$47.9M | 1% | 31 |
|
|
2022
Q1 | $55.7M | Sell |
99,096
-40,881
| -29% | -$23M | 0.45% | 68 |
|
|
2021
Q4 | $106M | Buy |
139,977
+13,275
| +10% | +$10M | 0.77% | 36 |
|
|
2021
Q3 | $94.4M | Buy |
126,702
+13,827
| +12% | +$10.3M | 0.75% | 35 |
|
|
2021
Q2 | $72.8M | Buy |
112,875
+29,135
| +35% | +$18.8M | 0.63% | 47 |
|
|
2021
Q1 | $47.8M | Sell |
83,740
-25,131
| -23% | -$14.3M | 0.45% | 63 |
|
|
2020
Q4 | $63.6M | Sell |
108,871
-24,357
| -18% | -$14.2M | 0.66% | 46 |
|
|
2020
Q3 | $68.6M | Sell |
133,228
-65,030
| -33% | -$33.5M | 0.86% | 30 |
|
|
2020
Q2 | $89.7M | Sell |
198,258
-60,383
| -23% | -$27.3M | 1.21% | 20 |
|
|
2020
Q1 | $89.9K | Buy |
258,641
+146,088
| +130% | +$50.8K | 0.15% | 14 |
|
|
2019
Q4 | $40.7M | Buy |
112,553
+20,151
| +22% | +$7.28M | 0.51% | 61 |
|
|
2019
Q3 | $30M | Buy |
92,402
+35,638
| +63% | +$11.6M | 0.41% | 83 |
|
|
2019
Q2 | $17.2M | Buy |
56,764
+16,936
| +43% | +$5.15M | 0.2% | 144 |
|
|
2019
Q1 | $12.2M | Buy |
39,828
+20,477
| +106% | +$6.26M | 0.14% | 179 |
|
|
2018
Q4 | $4.49M | Sell |
19,351
-380
| -2% | -$88.2K | 0.06% | 219 |
|
|
2018
Q3 | $6.18M | Buy |
+19,731
| New | +$6.18M | 0.07% | 236 |
|